RecruitingNot ApplicableNCT06376565

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

Multilevel Health System Intervention to Increase Guideline-Concordant Surveillance Colonoscopy for High Risk Colon Polyps

Sponsor

Jonsson Comprehensive Cancer Center

Enrollment

1,680 participants

Start Date

Nov 8, 2023

Study Type

INTERVENTIONAL

Conditions

Colorectal Carcinoma

Summary

This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This trial studies why some patients with high-risk colon polyps do not get recommended follow-up colonoscopies and tests strategies to improve surveillance rates. **You may be eligible if...** - You are a patient aged 45–75 who was diagnosed with a high-risk colon polyp in the past 5 years, OR - You are a healthcare provider or administrator involved in colon cancer screening at a participating clinic **You may NOT be eligible if...** - You have a personal history of colorectal cancer, inflammatory bowel disease, or a polyposis syndrome - Your high-risk polyp diagnosis is not confirmed by chart review Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.